MarketCap
Facebook
X
TelegramAnnual report 2021
added 12-23-2023
Neovasc Cash Conversion Cycle 2011-2026 | NVCN
Annual Cash Conversion Cycle Neovasc
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 81.2 | -37 | -18.8 | -2.83 | 22.6 | 46.1 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 81.2 | -37 | 15.2 |
Cash Conversion Cycle of other stocks in the Medical devices industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
104 | - | - | $ 1.77 B |  USA |
 |
AdaptHealth Corp.
AHCO
|
20.1 | $ 13.08 | 2.19 % | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
271 | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
Avinger
AVGR
|
335 | - | -20.74 % | $ 369 K | USA |
 |
Lianluo Smart Limited
LLIT
|
94.1 | - | 24.59 % | $ 44.8 M |  China |
 |
Axonics Modulation Technologies
AXNX
|
299 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-81.2 | - | 1.37 % | $ 20.5 M | USA |
 |
BIOLASE
BIOL
|
129 | - | -13.19 % | $ 166 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
174 | - | -5.86 % | $ 30.6 M | USA |
 |
Conformis
CFMS
|
165 | - | - | $ 16.4 M | USA |
 |
Cytosorbents Corporation
CTSO
|
104 | $ 0.61 | -2.58 % | $ 38 M | USA |
 |
Apollo Endosurgery
APEN
|
156 | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
44.3 | $ 3.22 | - | $ 121 M |  France |
 |
Cardiovascular Systems
CSII
|
172 | - | 0.15 % | $ 844 M | USA |
 |
ClearPoint Neuro
CLPT
|
217 | $ 11.21 | -4.84 % | $ 317 M | USA |
 |
Globus Medical
GMED
|
314 | $ 93.7 | -1.24 % | $ 12.7 B | USA |
 |
Helius Medical Technologies
HSDT
|
18.2 | $ 2.12 | -1.85 % | $ 1.29 M | USA |
 |
Dynatronics Corporation
DYNT
|
80.5 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
32.7 | - | - | $ 10.2 M | USA |
 |
CryoLife, Inc.
CRY
|
183 | - | -4.14 % | $ 702 M | USA |
 |
Electromed
ELMD
|
180 | $ 26.0 | -1.48 % | $ 220 M | USA |
 |
Second Sight Medical Products
EYES
|
-29.6 | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
204 | - | -0.57 % | $ 7.12 M | USA |
 |
Soliton, Inc.
SOLY
|
-67.9 | - | -1.42 % | $ 435 M | USA |
 |
LivaNova PLC
LIVN
|
113 | $ 63.41 | -1.23 % | $ 3.46 B |  Britain |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-227 | - | 0.03 % | $ 1.58 B |  Israel |
 |
LENSAR
LNSR
|
85.4 | $ 5.21 | 2.36 % | $ 62.3 M | USA |
 |
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | USA |
 |
Pulmonx Corporation
LUNG
|
246 | $ 1.28 | 0.79 % | $ 52.1 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
714 | $ 15.82 | -2.29 % | $ 371 M | USA |
 |
Butterfly Network
BFLY
|
815 | $ 5.48 | 2.81 % | $ 1.16 B | USA |
 |
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | USA |
 |
Insulet Corporation
PODD
|
187 | $ 188.31 | -0.66 % | $ 13.2 B | USA |
 |
Delcath Systems
DCTH
|
258 | $ 10.84 | - | $ 388 M | USA |
 |
IRIDEX Corporation
IRIX
|
105 | $ 1.08 | 1.89 % | $ 18.3 M | USA |
 |
CONMED Corporation
CNMD
|
212 | $ 37.87 | -1.23 % | $ 1.18 B | USA |
 |
Inspire Medical Systems
INSP
|
248 | $ 55.07 | -2.2 % | $ 1.62 B | USA |
 |
Sintx Technologies
SINT
|
279 | $ 2.35 | -4.86 % | $ 6.52 M | USA |
 |
Integer Holdings Corporation
ITGR
|
96.8 | $ 85.35 | -0.78 % | $ 2.96 B | USA |
 |
PAVmed
PAVM
|
-1.03 K | $ 8.4 | -6.67 % | $ 5.63 M | USA |
 |
Invacare Corporation
IVC
|
214 | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
283 | $ 83.46 | -0.94 % | $ 48.8 B | USA |
 |
Stryker Corporation
SYK
|
337 | $ 329.01 | 0.46 % | $ 126 B | USA |
 |
MiMedx Group
MDXG
|
125 | $ 3.34 | -2.62 % | $ 494 M | USA |
 |
Tactile Systems Technology
TCMD
|
99.9 | $ 24.24 | -3.31 % | $ 554 M | USA |
 |
Nevro Corp.
NVRO
|
297 | - | - | $ 217 M | USA |